Lisa S. Westerberg

Lisa S. Westerberg

Auto-generated profile, based on publicly available information

Lisa S. Westerberg

Department of Microbiology Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
SNShi Yong Neo
Shi Yong Neo
YYYing Yang
Ying Yang
JRJulien Record
Julien Record
RMRan Ma
Ran Ma
XCXinsong Chen
Xinsong Chen
ALAndreas Lundqvist
Andreas Lundqvist
High levels of ecto-5′-nucleotidase (CD73) have been implicated in immune suppression and tumor progression, and have also been observed in cancer patients who progress on anti–PD-1 immunotherapy. Although regulatory T cells can express CD73 and inhibit T cell responses via the production of adenosine, less is known about CD73 expression in other immune cell populations. We found that tumor-infiltrating NK cells upregulate CD73 expression and the frequency of these CD73-positive NK cells correlated with larger tumor size in breast cancer patients. In addition, the expression of multiple alternative immune checkpoint receptors including LAG-3, VISTA, PD-1, and PD-L1 was significantly higher in CD73-positive NK cells than in CD73-negative NK cells. Mechanistically, NK cells transport CD73 in intracellular vesicles to the cell surface and the extracellular space via actin polymerization–dependent exocytosis upon engagement of 4-1BBL on tumor cells. These CD73-positive NK cells undergo transcriptional reprogramming and upregulate IL-10 production via STAT3 transcriptional activity, suppressing CD4-positive T cell proliferation and IFN-γ production. Taken together, our results support the notion that tumors can hijack NK cells as a means to escape immunity and that CD73 expression defines an inducible population of NK cells with immunoregulatory properties within the tumor microenvironment.

6 July 2021 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
XZXiaolei Zhou
Xiaolei Zhou
MSMadhurendra Singh
Madhurendra Singh
GSGema Sanz Santos
Gema Sanz Santos
VGVincent Guerlavais
Vincent Guerlavais
LCLuis A. Carvajal
Luis A. Carvajal
GSGalina Selivanova
Galina Selivanova
The repression of repetitive elements is an important facet of p53's function as a guardian of the genome. Paradoxically, we found that p53 activated by MDM2 inhibitors induced the expression of endogenous retroviruses (ERV) via increased occupancy on ERV promoters and inhibition of two major ERV repressors, histone demethylase LSD1 and DNA methyltransferase DNMT1. Double-stranded RNA stress caused by ERVs triggered type I/III interferon expression and antigen processing and presentation. Pharmacologic activation of p53 in vivo unleashed the IFN program, promoted T-cell infiltration, and significantly enhanced the efficacy of checkpoint therapy in an allograft tumor model. Furthermore, the MDM2 inhibitor ALRN-6924 induced a viral mimicry pathway and tumor inflammation signature genes in patients with melanoma. Our results identify ERV expression as the central mechanism whereby p53 induction overcomes tumor immune evasion and transforms tumor microenvironment to a favorable phenotype, providing a rationale for the synergy of MDM2 inhibitors and immunotherapy.Significance: We found that p53 activated by MDM2 inhibitors induced the expression of ERVs, in part via epigenetic factors LSD1 and DNMT1. Induction of IFN response caused by ERV derepression upon p53-targeting therapies provides a possibility to overcome resistance to immune checkpoint blockade and potentially transform “cold” tumors into “hot.”This article is highlighted in the In This Issue feature, p. 2945

25 September 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
VCVinicius Cotta-De-Almeida
Vinicius Cotta-De-Almeida
LWLisa Westerberg
Lisa Westerberg
MMMichel H. Maillard
Michel H. Maillard
DODilek Onaldi
Dilek Onaldi
HWHeather Wachtel
Heather Wachtel
SSScott B. Snapper
Scott B. Snapper
Although T cell dysfunction and lymphopenia are key features of immunodeficient patients with the Wiskott–Aldrich syndrome and Wiskott–Aldrich syndrome protein (WASP)-deficient mice, T cell development appears relatively normal. We hypothesized that N-WASP, a ubiquitously expressed homologue of WASP, may serve a redundant function with WASP. To examine the unique and redundant activities of WASP and N-WASP, we generated ES cells devoid of WASP and N-WASP [double knockout (DKO)] and used the RAG-2-deficient blastocyst complementation system to generate DKO lymphocytes. Moreover, we mated WASP KO mice with mice containing a conditionally targeted N-WASP allele and used the Cre-loxP system to generate mice lacking WASP and N-WASP in T cells [conditional DKO (cDKO)]. In both systems, N-WASP-deficient cells were indistinguishable from WT cells. In contrast, T cell development in DKO and cDKO mice was markedly altered, as shown by thymic hypocellularity and reduced numbers of peripheral T cells. We found that the combined activity of WASP and N-WASP was important for CD4−CD8−double-negative (DN)-to-CD4+CD8+double-positive (DP) cell transition, and this may be partly explained by reduced cycling DN3 cells. In addition, decreased migratory responses of CD4+CD8−and CD4−CD8+single-positive (SP) cells and increased percentage of CD69lowCD24lowand CD62LlowSP cells in cDKO cells imply retention of SP cells in the thymus. In summary, this study suggests that, although WASP serves a unique role for peripheral T cell function, T cell development depends on the combined activity of WASP and N-WASP.

1 February 2005 in Blood
Verified
Journal Article
Closed access
PDF file
LWLisa Westerberg
Lisa Westerberg
MLMalin Larsson
Malin Larsson
SHSamantha J. Hardy
Samantha J. Hardy
CFCarmen Fernández
Carmen Fernández
ATAdrian J. Thrasher
Adrian J. Thrasher
ESEva Severinson
Eva Severinson
The Wiskott-Aldrich syndrome protein (WASp) is mutated in the severe immunodeficiency disease Wiskott-Aldrich syndrome (WAS). The function of B cells and the physiologic alterations in WAS remain unclear. We show that B cells from WAS patients exhibited decreased motility and had reduced capacity to migrate, adhere homotypically, and form long protrusions after in vitro culture. WASp-deficient murine B cells also migrated less well to chemokines. Upon antigen challenge, WASp-deficient mice mounted a reduced and delayed humoral immune response to both T-cell–dependent and –independent antigens. This was at least in part due to deficient migration and homing of B cells. In addition, the germinal center reaction was reduced in WASp-deficient mice. Thus, WASp is crucial for optimal B-cell responses and plays a pivotal role in the primary humoral immune response.

8 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SYSolmaz Yazdani
Solmaz Yazdani
CSChristina Seitz
Christina Seitz
CCCan Cui
Can Cui
ALAnikó Lovik
Anikó Lovik
LPLu Pan
Lu Pan
FFFang Fang
Fang Fang
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, involving neuroinflammation and T cell infiltration in the central nervous system. However, the contribution of T cell responses to the pathology of the disease is not fully understood. Here we show, by flow cytometric analysis of blood and cerebrospinal fluid (CSF) samples of a cohort of 89 newly diagnosed ALS patients in Stockholm, Sweden, that T cell phenotypes at the time of diagnosis are good predictors of disease outcome. High frequency of CD4+FOXP3− effector T cells in blood and CSF is associated with poor survival, whereas high frequency of activated regulatory T (Treg) cells and high ratio between activated and resting Treg cells in blood are associated with better survival. Besides survival, phenotypic profiling of T cells could also predict disease progression rate. Single cell transcriptomics analysis of CSF samples shows clonally expanded CD4+ and CD8+ T cells in CSF, with characteristic gene expression patterns. In summary, T cell responses associate with and likely contribute to disease progression in ALS, supporting modulation of adaptive immunity as a viable therapeutic option.

15 September 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MBMichael P. Blundell
Michael P. Blundell
GBGerben Bouma
Gerben Bouma
JMJoao Metelo
Joao Metelo
AWAusten Worth
Austen Worth
YCYolanda Calle
Yolanda Calle
ATAdrian J. Thrasher
Adrian J. Thrasher
The Wiskott-Aldrich syndrome protein (WASp) is a key cytoskeletal regulator in hematopoietic cells. Covalent modification of a conserved tyrosine by phosphorylation has emerged as an important potential determinant of activity, although the physiological significance remains uncertain. In a murine knockin model, mutation resulting in inability to phosphorylate Y293 (Y293F) mimicked many features of complete WASp-deficiency. Although a phosphomimicking mutant Y293E conferred enhanced actin-polymerization, the cellular phenotype was similar due to functional dysregulation. Furthermore, steady-state levels of Y293E-WASp were markedly reduced compared to wild-type WASp and Y293F-WASp, although partially recoverable by treatment of cells with proteasome inhibitors. Consequently, tyrosine phosphorylation plays a critical role in normal activation of WASp in vivo, and is indispensible for multiple tasks including proliferation, phagocytosis, chemotaxis, and assembly of adhesion structures. Furthermore, it may target WASp for proteasome-mediated degradation, thereby providing a default mechanism for self-limiting stimulation of the Arp2/3 complex.